Package 25021-115-02
Brand: clindamycin
Generic: clindamycin phosphatePackage Facts
Identity
Package NDC
25021-115-02
Digits Only
2502111502
Product NDC
25021-115
Description
25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL
Marketing
Marketing Status
Brand
clindamycin
Generic
clindamycin phosphate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "4662502b-ce7c-4278-854d-cf8632ac9b83", "openfda": {"unii": ["EH6D7113I8"], "rxcui": ["1737244", "1737578", "1737581"], "spl_set_id": ["7a6967b3-5563-4bed-9eee-d400f800e799"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-02) / 2 mL in 1 VIAL", "package_ndc": "25021-115-02", "marketing_start_date": "20120515"}, {"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-04) / 4 mL in 1 VIAL", "package_ndc": "25021-115-04", "marketing_start_date": "20120515"}, {"sample": false, "description": "25 VIAL in 1 CARTON (25021-115-06) / 6 mL in 1 VIAL", "package_ndc": "25021-115-06", "marketing_start_date": "20120515"}], "brand_name": "Clindamycin", "product_id": "25021-115_4662502b-ce7c-4278-854d-cf8632ac9b83", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "25021-115", "generic_name": "Clindamycin Phosphate", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin", "active_ingredients": [{"name": "CLINDAMYCIN PHOSPHATE", "strength": "150 mg/mL"}], "application_number": "ANDA090108", "marketing_category": "ANDA", "marketing_start_date": "20120515", "listing_expiration_date": "20261231"}